<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nankai_Results skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nankai/Results</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Medigo Blue, free responsive template</TITLE></P><DIV class="responsive_menu"><UL class="main_menu"><LI><A href="https://2015.igem.org/Team:Nankai">Home</A></LI><LI><A href="#">Research &amp; Lab</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Measurement">Measurements</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A></LI></UL><LI><A href="#">Member</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Collaborations">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices">Human Practices</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Modeling">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices/iShare" target="_blank">iShare</A></LI></DIV><HEADER class="site-header"><DIV><DIV><DIV><DIV class="main-navigation"><NAV class="main-nav visible-md visible-lg"><UL class="sf-menu"><LI id="sideli"><A href="https://2015.igem.org/Team:Nankai/Practices/iShare" target="_blank">iShare</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Modeling">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices">Human Practices</A></LI><LI><A href="#">Member</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Collaborations">Collaborations</A></LI></UL><LI><A href="#">Research &amp; Lab</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Measurement">Measurements</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:Nankai">Home</A></LI></NAV><DIV class="hidemenu"><P><A href="#">menu</A></P></DIV></DIV></DIV></DIV></DIV></HEADER><DIV class="first-widget parallax" id="blog"><DIV class="parallax-overlay"><P>Your place: <A href="https://2015.igem.org/Team:Nankai">Home</A> &gt; <A href="https://2015.igem.org/Team:Nankai/Description">Project</A> &gt; <A href="https://2015.igem.org/Team:Nankai/Results">Result</A></P><DIV class="container pageTitle"><DIV class="row"><DIV class="col-md-6 col-sm-6"><H2 class="page-title">Project Result</H2></DIV></DIV></DIV></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-8 blog-posts"><H4>1. Promoter strength assay in <EM>Bacillus amyloliquefaciens</EM> NK-1</H4><P>Six candidate promoters were digested by reletive endonucleases and ligated to the verification vector pCB with a reporter gene <EM>bgaB</EM> which encodes β-galatosidase (Figure 1).</P><H6>Figure 1. Plasmids verification. Marker III (M), control plasmids(1), digested plasmids(2).</H6><P>As shown in Figure 2, promoter C2up is the strongest promoter, about 60 times stronger than P<SUB>bca</SUB>. Promoter P<SUB>amyA</SUB> and A<SUB>2up</SUB> are both strong promoters, about 45 and 42 times stronger than P<SUB>bca</SUB>. Promoter P43 and BJ27up, though, are weak promoters, about 5 times and 3 times stronger than P<SUB>bca</SUB>.</P><DIV class="midpic"><H6>Figure 2. Promoter strength assay in <EM>B.amyloliquefaciens</EM> NK-1.</H6></DIV><H4>2. Metabolic toggle switch function assay</H4><P>To verify the function of the metabolic toggle switch, the <EM>xylR</EM> gene was ligated into the pHT01 plasmid to construct a XylR expression plasmid pHT01-<EM>xylR</EM>. P<SUB>xyl</SUB> was ligated into the pCB plasmid to construct the reporter plasmid pCB-P<SUB>xyl</SUB>. The electrophoretograms of both plasmids are shown in Figure 3.</P><DIV class="midpic"><H6>Figure 3. Plasmids digested by double endonucleases. Marker III (M), control plasmids (1), digested plasmids(2).</H6></DIV><P>We transformed the plasmids pHT01-<EM>xylR</EM> and pCB-P<SUB>xyl</SUB> into the NK-1 strain, to verify the activity of metabolic toggle switch. Fresh colonies of <EM>B. amyloliquefaciens</EM> strains (NK-1 strain containing plasmids pHT01-<EM>xylR</EM> and pCB-P<SUB>xyl</SUB> and the control NK-1 strain containing plasmids pHT01 and pCB-P<SUB>xyl</SUB>) were first cultured overnight in test tubes containing 5 mL LB liquid and then inoculated into 100 mL fresh fermentation medium. We added 1mM IPTG into the medium after 12h of cultivation. The β-galactosidase activity were measured at 12h, 18h, 24h, 30h, 36h, 42h to test the effect of metabolic toggle switch on the expression of <EM>bgaB</EM>.</P><P>As shown in Figure 4, β-galactosidase enzyme activity dropped considerably after 30 hours of fermentation. The inhibited expression of <EM>bgsB</EM> in experiment group (NPP+IPTG) indicated that the metabolic toggle switch we constructed is functional in <EM>B. amyloliquefaciens</EM> NK-1 strain.</P><DIV class="midpic"><H6>Figure 4. Verification of the metabolic toggle switch’s function. IPTG was added to the medium after 12 h cultivation.</H6></DIV><H4>3. Metabolic toggle switch’s affect on γ-PGA production</H4><P>We first constructed a recombinant plasmid pKSU-P<SUB>xyl</SUB> (Figure 5) by intergrating P<SUB>xyl</SUB> promoter into plasmid pKSU. Then we inserted P<SUB>xyl</SUB> into the <EM>B. amyloliquefaciens</EM> NK-1’s chromosome by markerless gene replacement method (see it in experiment and protocols), to replace P<SUB>bca</SUB>, the orgianal promoter of <EM>pgsBCA</EM> genes (Figure 6). The genetrated strain was designated as <EM>B. amyloliquefaciens</EM> NK-TP.</P><DIV class="midpic"><H6>Figure 5. (A)pKSU-P<SUB>xyl</SUB> plasmid verification. (M)Marker III, (1)complete plasmids, (2) digested plasmids.(B) Confirmation of the <EM>B. amyloliquefaciens</EM> NK-TP. (M) Maker III, (1, 2) NK-TP strain , (3) NK-1 control strain.</H6></DIV><P>To find out the proper IPTG adding time, we added 1mM IPTG into the medium at different time points (0h, 3h, 6h, 9h, 12h, 15h, 18h, 21h and 24h). According to the γ-PGA fermentation results, we found that the proper IPTG adding time is 15 hours. The highest γ-PGA titer was 4.15 g/L which is about 62.5% higer than that of wild type NK-1 strain (2.55g/L) and 87.5% higher than that of control group (2.21g/L).</P><DIV class="midpic"><H6>Figure 6. The effects of IPTG adding time on γ-PGA production. 1mM IPTG was added into the medium at different time points 0h, 3h, 6h, 9h, 12h, 15h, 18h, 21h and 24h.</H6></DIV><H4>4. Replacement of promoters</H4><P>In order to replace promoter P<SUB>bca</SUB> (the original promoter of <EM>pgsBCA</EM>) with the candidate promoters, we constructed five promoter recombinant plasmids. As shown in Figure 7, the five promoter recombinant plasmids have been successfully constructed.</P><H6>Figure 7. Plasmids verification. Marker III (M), control plasmids (1), digested plasmids(2).</H6><P>Among those candidate promoters, the promoter BJ27up has been successfully inserted into the chromosome of <EM>B. amyloliquefaciens</EM> NK-TP (showed in Figure 8). The BJ27up promoter insertion strain was designated as NK-BJ27up.</P><DIV class="smallpic"><H6>Figure 8. Confirmation of the <EM>B. amyloliquefaciens</EM> NK-BJ27up. Marker III (M), NK-BJ27up (1,2,3), NK-1(4).</H6></DIV></DIV><DIV class="col-md-4"><DIV class="sidebar"><DIV class="sidebar-widget"><H6><A href="https://2015.igem.org/Team:Nankai/Description">Description</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/project_background">Background</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Experiments">Experiments &amp; Protocols</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Results">Results</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Design">Design - Pudding Health Kit</A></H6></DIV><DIV class="sidebar-widget"><P>NMR of γ-PGA produced by bacillus amyloliquefaciens NK-1.</P><P>NMR of pure γ-PGA.</P><P>In the progress of transferring <EM>E. coli</EM> suspension.</P><P>Our wiki constructors are working hard.</P></DIV></DIV></DIV></DIV></DIV><TITLE>Medigo Blue, free responsive template</TITLE><FOOTER class="site-footer"><DIV class="copyright-content"><DIV class="copyright-text"><P>Copyright © Nankai University </P><P> Nankai IGEM Team 2015</P></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></BODY></HTML>